Dr. Jeffrey S. Weber, deputy director of Perlmutter Cancer Center, in his lab with Dr. David M. Woods.
Photo: Karsten Moran
Sue Carrington, a Queens resident and patient at 嘿嘿视频鈥檚 , is surviving 聽thanks to immunotherapy drugs. This class of drugs 鈥渞emove the brakes鈥 on the body鈥檚 own immune system, unleashing T-cells to fight off cancer cells. After treatment, Carrington鈥檚 tumors鈥攖he ones she was told would kill her otherwise鈥攈ad shrunk.
, deputy director of Perlmutter Cancer Center, is a world-renowned leader in the study of immunotherapy. Dr. Weber, who has spearheaded major advances in its use against melanoma, likens the role of immunotherapy in the battle against cancer to the Western front during World War I. 鈥淚t鈥檚 a messy, brutal battle, with lots of setbacks and lives lost鈥 But we are making progress,鈥 he tells Politico NY.
Immunotherapy has shown its most positive progress in tumors that have the most genetic mutations, such as those resulting from tobacco use and excessive sun exposure. But there is still much work to be done to develop variations of immunotherapy that respond to spontaneous tumors like .
Read more from .
